Skip to main content
Premium Trial:

Request an Annual Quote

Bayer to Use New Roche Cell Analysis System

NEW YORK (GenomeWeb News) – Bayer Schering Pharma will used Roche’s xCELLigence System for real-time non-labeled cell analysis, Roche Applied Science said today.
 
Roche said Bayer is one of the first users of the recently introduced xCELLigence System, which is designed for a variety of applications including short-term kinetic analysis and assays for cell proliferation and cytotoxicity. Manfred Baier, head of Roche Applied Science, said that the firm expects pharma research to be a primary application area for the new system.
 
According to Roche, the system can perform label-free analysis of a 96-well plate in less than 15 seconds.
 
Further details of the agreement with Bayer were not disclosed.

The Scan

Quality Improvement Study Compares Molecular Tumor Boards, Central Consensus Recommendations

With 50 simulated cancer cases, researchers in JAMA Network Open compared molecular tumor board recommendations with central consensus plans at a dozen centers in Japan.

Lupus Heterogeneity Highlighted With Single-Cell Transcriptomes

Using single-cell RNA sequencing, researchers in Nature Communications tracked down immune and non-immune cell differences between discoid lupus erythematosus and systemic lupus erythematosus.

Rare Disease Clues Gleaned From Mobile Element Insertions in Exome Sequences

With an approach called MELT, researchers in the European Journal of Human Genetics uncovered mobile element insertions in exomes from 3,232 individuals with or without developmental or neurological abnormalities.

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.